N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide

C67H80F2N18O7 — CID 170541312

IUPACN-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESNC(=O)c1ncc(N2CCCCC2)nc1Nc1ccc(C2CCN(C3CN(c4ccc5c(c4NCCC4CC6(C4)CN(CC4CCC(n7cc(NC(=O)c8cnn9ccc(N%10CCOCC%10)nc89)c(C(F)F)n7)CC4)C6)C(=O)N(C4CCC(=O)NC4=O)C5=O)C3)CC2)cc1
InChIInChI=1S/C67H80F2N18O7/c68-59(69)56-49(75-63(90)48-32-73-85-25-19-52(77-62(48)85)83-26-28-94-29-27-83)37-86(79-56)45-10-4-40(5-11-45)34-80-38-67(39-80)30-41(31-67)16-20-71-57-50(13-12-47-55(57)66(93)87(65(47)92)51-14-15-54(88)78-64(51)91)84-35-46(36-84)81-23-17-43(18-24-81)42-6-8-44(9-7-42)74-61-58(60(70)89)72-33-53(76-61)82-21-2-1-3-22-82/h6-9,12-13,19,25,32-33,37,40-41,43,45-46,51,59,71H,1-5,10-11,14-18,20-24,26-31,34-36,38-39H2,(H2,70,89)(H,74,76)(H,75,90)(H,78,88,91)
InChIKeyPBTRYNSJRXWOPP-UHFFFAOYSA-N
MW1287.49 g/mol
LogP6.99
Rot. Bonds19

About N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide

N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 170541312) has the molecular formula C67H80F2N18O7 and a molecular weight of 1287.49 g/mol. Its IUPAC name is N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound NameN-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID170541312
Molecular FormulaC67H80F2N18O7
Molecular Weight1287.49 g/mol
Exact Mass1286.64
IUPAC NameN-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESNC(=O)c1ncc(N2CCCCC2)nc1Nc1ccc(C2CCN(C3CN(c4ccc5c(c4NCCC4CC6(C4)CN(CC4CCC(n7cc(NC(=O)c8cnn9ccc(N%10CCOCC%10)nc89)c(C(F)F)n7)CC4)C6)C(=O)N(C4CCC(=O)NC4=O)C5=O)C3)CC2)cc1
InChIInChI=1S/C67H80F2N18O7/c68-59(69)56-49(75-63(90)48-32-73-85-25-19-52(77-62(48)85)83-26-28-94-29-27-83)37-86(79-56)45-10-4-40(5-11-45)34-80-38-67(39-80)30-41(31-67)16-20-71-57-50(13-12-47-55(57)66(93)87(65(47)92)51-14-15-54(88)78-64(51)91)84-35-46(36-84)81-23-17-43(18-24-81)42-6-8-44(9-7-42)74-61-58(60(70)89)72-33-53(76-61)82-21-2-1-3-22-82/h6-9,12-13,19,25,32-33,37,40-41,43,45-46,51,59,71H,1-5,10-11,14-18,20-24,26-31,34-36,38-39H2,(H2,70,89)(H,74,76)(H,75,90)(H,78,88,91)
InChIKeyPBTRYNSJRXWOPP-UHFFFAOYSA-N
XLogP6.99
TPSA279.02 Ų
H-Bond Donors5
H-Bond Acceptors21
Rotatable Bonds19
Heavy Atoms94
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001287.49
LogP ≤ 56.99
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 170541312) is N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide is NC(=O)c1ncc(N2CCCCC2)nc1Nc1ccc(C2CCN(C3CN(c4ccc5c(c4NCCC4CC6(C4)CN(CC4CCC(n7cc(NC(=O)c8cnn9ccc(N%10CCOCC%10)nc89)c(C(F)F)n7)CC4)C6)C(=O)N(C4CCC(=O)NC4=O)C5=O)C3)CC2)cc1.
What is the InChIKey of N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is PBTRYNSJRXWOPP-UHFFFAOYSA-N. The full InChI is InChI=1S/C67H80F2N18O7/c68-59(69)56-49(75-63(90)48-32-73-85-25-19-52(77-62(48)85)83-26-28-94-29-27-83)37-86(79-56)45-10-4-40(5-11-45)34-80-38-67(39-80)30-41(31-67)16-20-71-57-50(13-12-47-55(57)66(93)87(65(47)92)51-14-15-54(88)78-64(51)91)84-35-46(36-84)81-23-17-43(18-24-81)42-6-8-44(9-7-42)74-61-58(60(70)89)72-33-53(76-61)82-21-2-1-3-22-82/h6-9,12-13,19,25,32-33,37,40-41,43,45-46,51,59,71H,1-5,10-11,14-18,20-24,26-31,34-36,38-39H2,(H2,70,89)(H,74,76)(H,75,90)(H,78,88,91).
What are the key properties of N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 1287.49 g/mol, XLogP of 6.99, 19 rotatable bonds, 5 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[4-[[6-[2-[[5-[3-[4-[4-[(3-carbamoyl-6-piperidin-1-ylpyrazin-2-yl)amino]phenyl]piperidin-1-yl]azetidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]ethyl]-2-azaspiro[3.3]heptan-2-yl]methyl]cyclohexyl]-3-(difluoromethyl)pyrazol-4-yl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 170541312), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).